Wed, March 22, 2023

Matthew Barcus Maintained (ANIX) at Strong Buy with Increased Target to $9 on, Mar 22nd, 2023

Matthew Barcus of Chardan Capital, Maintained "Anixa Biosciences, Inc." (ANIX) at Strong Buy with Increased Target from $8 to $9 on, Mar 22nd, 2023.

Matthew has made no other calls on ANIX in the last 4 months.



There is 1 other peer that has a rating on ANIX. Out of the 1 peers that are also analyzing ANIX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Yi Chen of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Tuesday, February 28th, 2023